 | • レポートコード：QAF27737 • 出版社/出版日：QYResearch / 2021年4月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のインフルエンザワクチン市場について種類別（全ウイルスワクチン、分割ウイルスワクチン、サブユニットワクチン、弱毒生ウイルスワクチン）、用途別（子供用（6ヶ月～3歳）、大人用、3歳以上子供用）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・インフルエンザワクチン市場の概要 ・世界の主要地域別インフルエンザワクチン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のインフルエンザワクチン市場規模2016-2021：種類別（全ウイルスワクチン、分割ウイルスワクチン、サブユニットワクチン、弱毒生ウイルスワクチン） ・世界のインフルエンザワクチン市場予測2012-2027：種類別（全ウイルスワクチン、分割ウイルスワクチン、サブユニットワクチン、弱毒生ウイルスワクチン） ・世界のインフルエンザワクチン市場規模2016-2021：用途別（子供用（6ヶ月～3歳）、大人用、3歳以上子供用） ・世界のインフルエンザワクチン市場予測2012-2027：用途別（子供用（6ヶ月～3歳）、大人用、3歳以上子供用） ・インフルエンザワクチンのアメリカ市場規模と予測2016-2021 ・インフルエンザワクチンのヨーロッパ市場規模と予測2016-2021 ・インフルエンザワクチンの中国市場規模と予測2016-2021 ・インフルエンザワクチンの日本市場規模と予測2016-2021 ・インフルエンザワクチンの東南アジア市場規模と予測2016-2021 ・インフルエンザワクチンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （CSL、GSK、Sanofi Pasteur、Mylan、AstraZeneca、Pfizer、Johnson & Johnson） ・インフルエンザワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・インフルエンザワクチンの市場動向・機会・課題 ・調査の結論 |
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The classification of Flu Vaccine includes Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines and Live Attenuated Virus Vaccines, and the proportion of Whole Virus Vaccines In 2018 is about 43%, and the proportion is in decreasing trend from 2012 to 2016.
Flu Vaccine is widely used for Children (6 months to 3 years) and for Adults and Children over 3 years. The most proportion of Flu Vaccine is For Adults and Children over 3 years, and the proportion In 2018 is about 75%.
The Europe in the EMEA is the largest consumption place, with a consumption market share nearly 80% In 2018. And in the major countries we mentioned in the report, Germany is the largest consumption place with the consumption market share of 12%. Following Russia, France is the second largest consumption region, with the proportion of 11%.
Market Analysis and Insights: Global Influenza Vaccine Market
The global Influenza Vaccine market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Influenza Vaccine Scope and Market Size
The global Influenza Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines
Segment by Application
For Children (6 months to 3 years)
For Adults and Children over 3 years
The Influenza Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Influenza Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson
1 Influenza Vaccine Market Overview
1.1 Influenza Vaccine Product Scope
1.2 Influenza Vaccine Segment by Type
1.2.1 Global Influenza Vaccine Sales by Type (2016 & 2021 & 2027)
1.2.2 Whole Virus Vaccines
1.2.3 Split Virus Vaccines
1.2.4 Subunit Vaccines
1.2.5 Live Attenuated Virus Vaccines
1.3 Influenza Vaccine Segment by Application
1.3.1 Global Influenza Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Influenza Vaccine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Influenza Vaccine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Influenza Vaccine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Influenza Vaccine Price Trends (2016-2027)
2 Influenza Vaccine Estimates and Forecasts by Region
2.1 Global Influenza Vaccine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Influenza Vaccine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Influenza Vaccine Sales Market Share by Region (2016-2021)
2.2.2 Global Influenza Vaccine Revenue Market Share by Region (2016-2021)
2.3 Global Influenza Vaccine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Influenza Vaccine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Influenza Vaccine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Influenza Vaccine Estimates and Projections (2016-2027)
2.4.2 Europe Influenza Vaccine Estimates and Projections (2016-2027)
2.4.3 China Influenza Vaccine Estimates and Projections (2016-2027)
2.4.4 Japan Influenza Vaccine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Influenza Vaccine Estimates and Projections (2016-2027)
2.4.6 India Influenza Vaccine Estimates and Projections (2016-2027)
3 Global Influenza Vaccine Competition Landscape by Players
3.1 Global Top Influenza Vaccine Players by Sales (2016-2021)
3.2 Global Top Influenza Vaccine Players by Revenue (2016-2021)
3.3 Global Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Vaccine as of 2020)
3.4 Global Influenza Vaccine Average Price by Company (2016-2021)
3.5 Manufacturers Influenza Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Influenza Vaccine Market Size by Type
4.1 Global Influenza Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Influenza Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Influenza Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Global Influenza Vaccine Price by Type (2016-2021)
4.2 Global Influenza Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Influenza Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Influenza Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Global Influenza Vaccine Price Forecast by Type (2022-2027)
5 Global Influenza Vaccine Market Size by Application
5.1 Global Influenza Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Influenza Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Influenza Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Global Influenza Vaccine Price by Application (2016-2021)
5.2 Global Influenza Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Influenza Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Influenza Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Influenza Vaccine Price Forecast by Application (2022-2027)
6 North America Influenza Vaccine Market Facts & Figures
6.1 North America Influenza Vaccine Sales by Company
6.1.1 North America Influenza Vaccine Sales by Company (2016-2021)
6.1.2 North America Influenza Vaccine Revenue by Company (2016-2021)
6.2 North America Influenza Vaccine Sales Breakdown by Type
6.2.1 North America Influenza Vaccine Sales Breakdown by Type (2016-2021)
6.2.2 North America Influenza Vaccine Sales Breakdown by Type (2022-2027)
6.3 North America Influenza Vaccine Sales Breakdown by Application
6.3.1 North America Influenza Vaccine Sales Breakdown by Application (2016-2021)
6.3.2 North America Influenza Vaccine Sales Breakdown by Application (2022-2027)
7 Europe Influenza Vaccine Market Facts & Figures
7.1 Europe Influenza Vaccine Sales by Company
7.1.1 Europe Influenza Vaccine Sales by Company (2016-2021)
7.1.2 Europe Influenza Vaccine Revenue by Company (2016-2021)
7.2 Europe Influenza Vaccine Sales Breakdown by Type
7.2.1 Europe Influenza Vaccine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Influenza Vaccine Sales Breakdown by Type (2022-2027)
7.3 Europe Influenza Vaccine Sales Breakdown by Application
7.3.1 Europe 139 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 139 Sales Breakdown by Application (2022-2027)
8 China Influenza Vaccine Market Facts & Figures
8.1 China Influenza Vaccine Sales by Company
8.1.1 China Influenza Vaccine Sales by Company (2016-2021)
8.1.2 China Influenza Vaccine Revenue by Company (2016-2021)
8.2 China Influenza Vaccine Sales Breakdown by Type
8.2.1 China Influenza Vaccine Sales Breakdown by Type (2016-2021)
8.2.2 China Influenza Vaccine Sales Breakdown by Type (2022-2027)
8.3 China Influenza Vaccine Sales Breakdown by Application
8.3.1 China 243 Sales Breakdown by Application (2016-2021)
8.3.2 China 243 Sales Breakdown by Application (2022-2027)
9 Japan Influenza Vaccine Market Facts & Figures
9.1 Japan Influenza Vaccine Sales by Company
9.1.1 Japan Influenza Vaccine Sales by Company (2016-2021)
9.1.2 Japan Influenza Vaccine Revenue by Company (2016-2021)
9.2 Japan Influenza Vaccine Sales Breakdown by Type
9.2.1 Japan Influenza Vaccine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Influenza Vaccine Sales Breakdown by Type (2022-2027)
9.3 Japan Influenza Vaccine Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Influenza Vaccine Market Facts & Figures
10.1 Southeast Asia Influenza Vaccine Sales by Company
10.1.1 Southeast Asia Influenza Vaccine Sales by Company (2016-2021)
10.1.2 Southeast Asia Influenza Vaccine Revenue by Company (2016-2021)
10.2 Southeast Asia Influenza Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Influenza Vaccine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Influenza Vaccine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Influenza Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)
11 India Influenza Vaccine Market Facts & Figures
11.1 India Influenza Vaccine Sales by Company
11.1.1 India Influenza Vaccine Sales by Company (2016-2021)
11.1.2 India Influenza Vaccine Revenue by Company (2016-2021)
11.2 India Influenza Vaccine Sales Breakdown by Type
11.2.1 India Influenza Vaccine Sales Breakdown by Type (2016-2021)
11.2.2 India Influenza Vaccine Sales Breakdown by Type (2022-2027)
11.3 India Influenza Vaccine Sales Breakdown by Application
11.3.1 India Influenza Vaccine Sales Breakdown by Application (2016-2021)
11.3.2 India Influenza Vaccine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Influenza Vaccine Business
12.1 CSL
12.1.1 CSL Corporation Information
12.1.2 CSL Business Overview
12.1.3 CSL Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 CSL Influenza Vaccine Products Offered
12.1.5 CSL Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Business Overview
12.2.3 GSK Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GSK Influenza Vaccine Products Offered
12.2.5 GSK Recent Development
12.3 Sanofi Pasteur
12.3.1 Sanofi Pasteur Corporation Information
12.3.2 Sanofi Pasteur Business Overview
12.3.3 Sanofi Pasteur Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sanofi Pasteur Influenza Vaccine Products Offered
12.3.5 Sanofi Pasteur Recent Development
12.4 Mylan
12.4.1 Mylan Corporation Information
12.4.2 Mylan Business Overview
12.4.3 Mylan Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Mylan Influenza Vaccine Products Offered
12.4.5 Mylan Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Corporation Information
12.5.2 AstraZeneca Business Overview
12.5.3 AstraZeneca Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 AstraZeneca Influenza Vaccine Products Offered
12.5.5 AstraZeneca Recent Development
12.6 Pfizer
12.6.1 Pfizer Corporation Information
12.6.2 Pfizer Business Overview
12.6.3 Pfizer Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Pfizer Influenza Vaccine Products Offered
12.6.5 Pfizer Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Corporation Information
12.7.2 Johnson & Johnson Business Overview
12.7.3 Johnson & Johnson Influenza Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Johnson & Johnson Influenza Vaccine Products Offered
12.7.5 Johnson & Johnson Recent Development
…
13 Influenza Vaccine Manufacturing Cost Analysis
13.1 Influenza Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Influenza Vaccine
13.4 Influenza Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Influenza Vaccine Distributors List
14.3 Influenza Vaccine Customers
15 Market Dynamics
15.1 Influenza Vaccine Market Trends
15.2 Influenza Vaccine Drivers
15.3 Influenza Vaccine Market Challenges
15.4 Influenza Vaccine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Influenza Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Influenza Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Influenza Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Influenza Vaccine Sales (K Doses) by Region (2016-2021)
Table 5. Global Influenza Vaccine Sales Market Share by Region (2016-2021)
Table 6. Global Influenza Vaccine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Influenza Vaccine Revenue Share by Region (2016-2021)
Table 8. Global Influenza Vaccine Sales (K Doses) Forecast by Region (2022-2027)
Table 9. Global Influenza Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Influenza Vaccine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Influenza Vaccine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Influenza Vaccine Sales (K Doses) of Key Companies (2016-2021)
Table 13. Global Influenza Vaccine Sales Share by Company (2016-2021)
Table 14. Global Influenza Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Influenza Vaccine Revenue Share by Company (2016-2021)
Table 16. Global Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Vaccine as of 2020)
Table 17. Global Influenza Vaccine Average Price (USD/Doses) of Key Company (2016-2021)
Table 18. Manufacturers Influenza Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Influenza Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Influenza Vaccine Sales (K Doses) by Type (2016-2021)
Table 22. Global Influenza Vaccine Sales Share by Type (2016-2021)
Table 23. Global Influenza Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Influenza Vaccine Price (USD/Doses) by Type (2016-2021)
Table 25. Global Influenza Vaccine Sales Share by Type (2022-2027)
Table 26. Global Influenza Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Influenza Vaccine Revenue Share by Type (2022-2027)
Table 28. Global Influenza Vaccine Price (USD/Doses) by Type (2022-2027)
Table 29. Global Influenza Vaccine Sales (K Doses) by Application (2016-2021)
Table 30. Global Influenza Vaccine Sales Share by Application (2016-2021)
Table 31. Global Influenza Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Influenza Vaccine Price (USD/Doses) by Application (2016-2021)
Table 33. Global Influenza Vaccine Sales (K Doses) by Application (2022-2027)
Table 34. Global Influenza Vaccine Sales Share by Application (2022-2027)
Table 35. Global Influenza Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Influenza Vaccine Revenue Share by Application (2022-2027)
Table 37. Global Influenza Vaccine Price (USD/Doses) by Application (2022-2027)
Table 38. North America Influenza Vaccine Sales (K Doses) by Company (2016-2021)
Table 39. North America Influenza Vaccine Sales Market Share by Company (2016-2021)
Table 40. North America Influenza Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Influenza Vaccine Revenue Market Share by Company (2016-2021)
Table 42. North America Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 43. North America Influenza Vaccine Sales Market Share by Type (2016-2021)
Table 44. North America Influenza Vaccine Sales by Type (2022-2027) & (K Doses)
Table 45. North America Influenza Vaccine Sales Market Share by Type (2022-2027)
Table 46. North America Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 47. North America Influenza Vaccine Sales Market Share by Application (2016-2021)
Table 48. North America Influenza Vaccine Sales by Application (2022-2027) & (K Doses)
Table 49. North America Influenza Vaccine Sales Market Share by Application (2022-2027)
Table 50. Europe Influenza Vaccine Sales (K Doses) by Company (2016-2021)
Table 51. Europe Influenza Vaccine Sales Market Share by Company (2016-2021)
Table 52. Europe Influenza Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Influenza Vaccine Revenue Market Share by Company (2016-2021)
Table 54. Europe Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 55. Europe Influenza Vaccine Sales Market Share by Type (2016-2021)
Table 56. Europe Influenza Vaccine Sales by Type (2022-2027) & (K Doses)
Table 57. Europe Influenza Vaccine Sales Market Share by Type (2022-2027)
Table 58. Europe Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 59. Europe Influenza Vaccine Sales Market Share by Application (2016-2021)
Table 60. Europe Influenza Vaccine Sales by Application (2022-2027) & (K Doses)
Table 61. Europe Influenza Vaccine Sales Market Share by Application (2022-2027)
Table 62. China Influenza Vaccine Sales (K Doses) by Company (2016-2021)
Table 63. China Influenza Vaccine Sales Market Share by Company (2016-2021)
Table 64. China Influenza Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Influenza Vaccine Revenue Market Share by Company (2016-2021)
Table 66. China Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 67. China Influenza Vaccine Sales Market Share by Type (2016-2021)
Table 68. China Influenza Vaccine Sales by Type (2022-2027) & (K Doses)
Table 69. China Influenza Vaccine Sales Market Share by Type (2022-2027)
Table 70. China Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 71. China Influenza Vaccine Sales Market Share by Application (2016-2021)
Table 72. China Influenza Vaccine Sales by Application (2022-2027) & (K Doses)
Table 73. China Influenza Vaccine Sales Market Share by Application (2022-2027)
Table 74. Japan Influenza Vaccine Sales (K Doses) by Company (2016-2021)
Table 75. Japan Influenza Vaccine Sales Market Share by Company (2016-2021)
Table 76. Japan Influenza Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Influenza Vaccine Revenue Market Share by Company (2016-2021)
Table 78. Japan Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 79. Japan Influenza Vaccine Sales Market Share by Type (2016-2021)
Table 80. Japan Influenza Vaccine Sales by Type (2022-2027) & (K Doses)
Table 81. Japan Influenza Vaccine Sales Market Share by Type (2022-2027)
Table 82. Japan Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 83. Japan Influenza Vaccine Sales Market Share by Application (2016-2021)
Table 84. Japan Influenza Vaccine Sales by Application (2022-2027) & (K Doses)
Table 85. Japan Influenza Vaccine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Influenza Vaccine Sales (K Doses) by Company (2016-2021)
Table 87. Southeast Asia Influenza Vaccine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Influenza Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Influenza Vaccine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 91. Southeast Asia Influenza Vaccine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Influenza Vaccine Sales by Type (2022-2027) & (K Doses)
Table 93. Southeast Asia Influenza Vaccine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 95. Southeast Asia Influenza Vaccine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Influenza Vaccine Sales by Application (2022-2027) & (K Doses)
Table 97. Southeast Asia Influenza Vaccine Sales Market Share by Application (2022-2027)
Table 98. India Influenza Vaccine Sales (K Doses) by Company (2016-2021)
Table 99. India Influenza Vaccine Sales Market Share by Company (2016-2021)
Table 100. India Influenza Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Influenza Vaccine Revenue Market Share by Company (2016-2021)
Table 102. India Influenza Vaccine Sales by Type (2016-2021) & (K Doses)
Table 103. India Influenza Vaccine Sales Market Share by Type (2016-2021)
Table 104. India Influenza Vaccine Sales by Type (2022-2027) & (K Doses)
Table 105. India Influenza Vaccine Sales Market Share by Type (2022-2027)
Table 106. India Influenza Vaccine Sales by Application (2016-2021) & (K Doses)
Table 107. India Influenza Vaccine Sales Market Share by Application (2016-2021)
Table 108. India Influenza Vaccine Sales by Application (2022-2027) & (K Doses)
Table 109. India Influenza Vaccine Sales Market Share by Application (2022-2027)
Table 110. CSL Corporation Information
Table 111. CSL Description and Business Overview
Table 112. CSL Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 113. CSL Influenza Vaccine Product
Table 114. CSL Recent Development
Table 115. GSK Corporation Information
Table 116. GSK Description and Business Overview
Table 117. GSK Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 118. GSK Influenza Vaccine Product
Table 119. GSK Recent Development
Table 120. Sanofi Pasteur Corporation Information
Table 121. Sanofi Pasteur Description and Business Overview
Table 122. Sanofi Pasteur Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 123. Sanofi Pasteur Influenza Vaccine Product
Table 124. Sanofi Pasteur Recent Development
Table 125. Mylan Corporation Information
Table 126. Mylan Description and Business Overview
Table 127. Mylan Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 128. Mylan Influenza Vaccine Product
Table 129. Mylan Recent Development
Table 130. AstraZeneca Corporation Information
Table 131. AstraZeneca Description and Business Overview
Table 132. AstraZeneca Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 133. AstraZeneca Influenza Vaccine Product
Table 134. AstraZeneca Recent Development
Table 135. Pfizer Corporation Information
Table 136. Pfizer Description and Business Overview
Table 137. Pfizer Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 138. Pfizer Influenza Vaccine Product
Table 139. Pfizer Recent Development
Table 140. Johnson & Johnson Corporation Information
Table 141. Johnson & Johnson Description and Business Overview
Table 142. Johnson & Johnson Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2016-2021)
Table 143. Johnson & Johnson Influenza Vaccine Product
Table 144. Johnson & Johnson Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Influenza Vaccine Distributors List
Table 148. Influenza Vaccine Customers List
Table 149. Influenza Vaccine Market Trends
Table 150. Influenza Vaccine Market Drivers
Table 151. Influenza Vaccine Market Challenges
Table 152. Influenza Vaccine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Vaccine Product Picture
Figure 2. Global Influenza Vaccine Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Influenza Vaccine Sales Market Share by Application in 2021 & 2027
Figure 6. For Children (6 months to 3 years) Examples
Figure 7. For Adults and Children over 3 years Examples
Figure 8. Global Influenza Vaccine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Influenza Vaccine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Influenza Vaccine Sales (K Doses) Growth Rate (2016-2027)
Figure 11. Global Influenza Vaccine Price Trends Growth Rate (2016-2027) (USD/Doses)
Figure 12. Global Influenza Vaccine Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Influenza Vaccine Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Influenza Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Influenza Vaccine Sales (K Doses) Growth Rate (2016-2027)
Figure 16. Europe Influenza Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Influenza Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Influenza Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Influenza Vaccine Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Influenza Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Influenza Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Influenza Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Influenza Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Influenza Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Influenza Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Influenza Vaccine Players Market Share by Revenue in Influenza Vaccine: 2016 & 2020
Figure 27. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Influenza Vaccine Revenue Share by Type (2016-2021)
Figure 29. Global Influenza Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Influenza Vaccine Revenue Share by Application (2016-2021)
Figure 31. Global Influenza Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Influenza Vaccine Sales Market Share by Type in 2020
Figure 33. North America Influenza Vaccine Sales Market Share by Application in 2020
Figure 34. Europe Influenza Vaccine Sales Market Share by Type in 2020
Figure 35. Europe Influenza Vaccine Sales Market Share by Application in 2020
Figure 36. China Influenza Vaccine Sales Market Share by Type in 2020
Figure 37. China Influenza Vaccine Sales Market Share by Application in 2020
Figure 38. Japan Influenza Vaccine Sales Market Share by Type in 2020
Figure 39. Japan Influenza Vaccine Sales Market Share by Application in 2020
Figure 40. Southeast Asia Influenza Vaccine Sales Market Share by Type in 2020
Figure 41. Southeast Asia Influenza Vaccine Sales Market Share by Application in 2020
Figure 42. India Influenza Vaccine Sales Market Share by Type in 2020
Figure 43. India Influenza Vaccine Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Influenza Vaccine
Figure 46. Manufacturing Process Analysis of Influenza Vaccine
Figure 47. Influenza Vaccine Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
犬用インフルエンザワクチンのグローバル市場調査 2019年 The global Canine Influenza Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Canine Influenza Vaccine volume and value at global level, regional level and company level. From a global perspec…- 馬用インフルエンザワクチンのグローバル市場調査 2019年 The global Equine Influenza Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Equine Influenza Vaccine volume and value at global level, regional level and company level. From a global perspec…
- インフルエンザワクチンのグローバル市場調査 2019年 The global Flu Vaccine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Flu Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represen…
- インフルエンザAウイルス、H3N2サブタイプ感染薬のグローバル市場調査 2019年 The global Influenza A Virus, H3N2 Subtype Infections Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Influenza A Virus, H3N2 Subtype Infections Drug volume and value at global level, regional …
- 水痘ウイルス生ワクチンのグローバル市場調査 2019年 The global Varicella Virus Vaccine Live market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Varicella Virus Vaccine Live volume and value at global level, regional level and company level. From a global…